Global Automated Immunoassay Analyzers Market Size Likely to Reach at a CAGR of 15.35% By 2034

Global Automated Immunoassay Analyzers Market size was valued at USD 24.34 Billion in 2025 and is anticipated to reach around USD 75.31 Billion by 2034, expanding at a CAGR of 15.35% over the forecast period 2025 – 2034.

Automated Immunoassay Analyzers Market Growth Factors and Dynamics

• The automated analyzers market is experiencing a rapid increase in the demand for point-of-care testing (POCT), facilitating quicker diagnosis and treatment of diseases. Diagnostic tests are conducted at or near the site of patient care during point-of-care testing, and the results are available within minutes. POCT is particularly beneficial in remote or resource-limited contexts, where access to laboratory testing may be restricted, and in emergencies, where rapid diagnosis is essential. As a result of their ability to provide swift results with high accuracy, automated analyzers are being utilized more frequently in point-of-care testing.

• These analyzers utilize sophisticated technologies, including microfluidics, biosensors, and lab-on-a-chip devices, to conduct numerous tests simultaneously in a compact and portable format. Blood glucose meters, cardiac markers, haematology analyzers, and infectious disease assays are among the automated analyzers employed in POCT.

• By reducing the necessity for costly laboratory testing, hospital admissions, and unnecessary treatments, point-of-care testing can contribute to the reduction of healthcare costs. Patients highly value convenience and rapid results, and point-of-care testing provides both. POCT has the potential to enhance patient satisfaction by reducing wait times and facilitating the rapid provision of treatment.

• The expanding utilization of point-of-care testing in emerging markets, where laboratory testing may be restricted, and the growing emphasis on personalized medicine necessitate rapid and precise diagnostic testing. In general, the automated analyzers market is anticipated to continue to expand during the forecast period due to the increasing demand for point-of-care testing.

• One of the critical factors that is anticipated to stimulate the growth of the automated immunoassay analyzers market is the increasing prevalence of infectious diseases. It is crucial to detect infectious diseases early to mitigate the risk of grievous bodily harm. Consequently, the precise and accurate screening of various infections, including Hepatitis, influenza, STDs, and a host of others, in a short amount of time is expected to be a significant market growth factor. Additionally, the early detection of maladies has been intensified to prevent complications through diagnostic testing, which has heightened awareness of the condition.

Automated Immunoassay Analyzers Market Significant Market Opportunities

• The subsequent factors are anticipated to generate opportunities during the forecast period.

• Machine learning (ML) and artificial intelligence (AI) integration.

• Emphasize personalized medicine.

• Working in conjunction with academic research institutions

Report Scope

Automated Immunoassay Analyzers Market Impact of COVID-19

The automated immunoassay analyzers market revenue in 2020 was adversely affected by the recent COVID-19 pandemic. Numerous restrictions, including nationwide lockdowns, were implemented in various countries worldwide to prevent the infection from spreading.

The COVID-19 outbreak significantly impacted the immunoassay analyzers market and the entire healthcare industry. The market revenue was affected by various factors, such as the interruption of non-emergent medical services, equipment demand and supply shortages, and supply chain disturbances, among other disruptions.

The industry experienced a rapid recovery and an incremental increase in the year-on-year growth trend in the years that followed as the COVID-19 infection rate decreased. Nevertheless, the decrease in the number of patients accelerated the product adoption rate and positively impacted the market’s growth.

Automated Immunoassay Analyzers Market Industry News

• In November 2021, Boditech Med, a Korean company, introduced its latest Automated Immunoassay Analyzer with Blood Collection Tube. It is equipped with the distinctive ability to conduct ten parallel experiments for each distinct parameter. This strategic development is intended to increase the company’s revenue and industry presence in the years ahead.

• The fully automated analyzers that Thermo Fisher Scientific has introduced are designed explicitly for enzyme assay applications. This launch occurred in September 2021. The new analyzer systems integrate hardware and newly developed software to enable entirely automated incubation settings, precise measurement calculations, and reagent additions. This development is instrumental in the company’s expansion of its product portfolio and business growth.

List of the prominent players in the Automated Immunoassay Analyzers Market:

• Abbott Laboratories
• Arlington Scientific Inc.
• Bio-Rad Laboratories Inc.
• Biobase Biodusty(Shandong), Co. Ltd.
• bioMerieux SA
• Carolina Liquid Chemistries Corp.
• Charles River Laboratories
• Chengdu Vacure Biotechnology Co. Ltd.
• Danaher Corporation
• Hoffmann-La Roche AG
• Getein Biotech Inc.
• Hipro Biotechnology Co. Ltd.
• Illumina Inc.
• Laboratory Corporation of America Holdings
• Medline Industries LP
• Meril Life Sciences Pvt. Ltd.
• PerkinElmer Inc.
• Qiagen N.V.
• Randox Laboratories
• Siemens Healthineers
• Sysmex Corporation
• Arlington Scientific
• Becton Dickinson and Company
• Carolina Liquid Chemistries Corporation
• Roche Diagnostics
• BioMerieux
• Aesku Diagnostics
• Others

The Automated Immunoassay Analyzers Market is segmented as follows:

By Product

• Immunofluorescence
• Chemiluminescence
• Enzyme Linked Fluorescent System
• Radioimmunoassay

By Application

• Infectious Diseases
• Endocrinology
• Drug Monitoring
• Chronic Diseases
• Allergy Testing

By End User

• Academic Research Institutes
• Biotech And Pharma Companies
• Hospitals
• Diagnostic Test Laboratories
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America